))
Avastin combined with other cancer drug may stop spread of brain cancer
Archived series ("Inactive feed" status)
When?
This feed was archived on August 21, 2018 01:38 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 53132436 series 55715
Content provided by Insidermedicine Daily News (Video). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Insidermedicine Daily News (Video) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
(February 14, 2013 - Insidermedicine)
From Minnesota – Avastin combined with a cancer drug may stop brain cancer from spreading, according to a report published in PLOS ONE. Researchers studied a mouse model of brain cancer, administering bevacizumab alone, dasatinib alone, and a combo of the two drugs. They found that Avastin alone temporarily stopped the brain cancer but consequently encouraged the tumor to spread and become more aggressive. Use of both drugs, however, shrank the tumors and also stopped subsequent spread
2469 episodes
Share
